Trichostatin A Enhances Glutamate Transporter GLT-1 mRNA Levels in C6 Glioma Cells via Neurosteroid-Mediated Cell Differentiation
Authors:
- 19 June 2012
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 49 (1) , 21-27
Abstract
The neurotoxic effects of excitatory amino acids (EAAs) are suggested to be connected with the chronic loss of neuronal cells, thereby being responsible for the age-related neurodegenerative diseases. Therefore, it seems conceivable that the excitatory amino acid transporters may contribute to the protection of neuronal cells against the excitotoxic damage by facilitating the removal of EAAs from the brain tissue. On the other hand, previous studies have suggested that glial cell differentiation may be involved in the protection and recovery of neural function probably through the elevation of BDNF gene expression in the brain. Based on these findings, histone deacetylase (HDAC) inhibitors are assumed to induce glutamate transporter-1 (GLT-1) gene expression probably through the promotion of glial cell differentiation. Then, we examined the effects of HDAC inhibitors on GLT-1 mRNA levels in rat C6 glioma cells and found that trichostatin A can induce GLT-1 gene transcription following steroid 5α-reductase and GFAP gene expression. Therefore, it seems conceivable that glial cell differentiation may play a potential role in the removal of EAAs probably through the expression of GLT-1, thereby being involved in the protection of neuronal cells against the chronic excitotoxic insults in the brain.Keywords
This publication has 35 references indexed in Scilit:
- Role of Excitatory Amino Acid Transporter‐2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeuticsJournal of Cellular Physiology, 2010
- Cyclin‐dependent kinase 9 forms a complex with GATA4 and is involved in the differentiation of mouse ES cells into cardiomyocytesJournal of Cellular Physiology, 2010
- Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levelsNeurochemistry International, 2009
- Glutamate, excitotoxicity, and programmed cell death in parkinson diseaseExperimental Neurology, 2009
- Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosisExpert Opinion on Therapeutic Targets, 2007
- Progesterone increases brain‐derived neuroptrophic factor expression and protects against glutamate toxicity in a mitogen‐activated protein kinase‐ and phosphoinositide‐3 kinase‐dependent manner in cerebral cortical explantsJournal of Neuroscience Research, 2007
- Transporters forL‐glutamate: An update on their molecular pharmacology and pathological involvementBritish Journal of Pharmacology, 2007
- Impact of Progestins on Estrogen-Induced Neuroprotection: Synergy by Progesterone and 19-Norprogesterone and Antagonism by Medroxyprogesterone AcetateEndocrinology, 2002
- Neuroprotective properties of 17β‐estradiol, progesterone, and raloxifene in MPTP C57Bl/6 miceSynapse, 2001
- Progesterone Facilitates Cognitive Recovery and Reduces Secondary Neuronal Loss Caused by Cortical Contusion Injury in Male RatsExperimental Neurology, 1994